Poseida Therapeutics (PSTX) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.42
-0.21
0
0.21

Details

Expected EPS
-0.4175
Actual EPS
0.21
Surprise EPS
0.63
Surprise Percent
+150.3%

Description

Poseida Therapeutics (PSTX) has reported earnings of 0.21 per share for Q4 2024.

0 Comments

Share your thoughts